5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine

C96H107B3Br2F6N26O19 — CID 164973938

IUPAC5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine
SMILESCC(N)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(-c2ccn3nc(N)nc3c2)cn(C)c1=O)c1ccccc1OC(F)(F)F.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccn3nc(N)nc3c2)OC1(C)C.COC(=O)c1cc(-c2ccn3nc(N)nc3c2)cn(C)c1=O.COC(=O)c1cc(Br)cn(C)c1=O.Cn1cc(-c2ccn3nc(N)nc3c2)cc(C(=O)O)c1=O.Nc1nc2cc(Br)ccn2n1
InChIInChI=1S/C22H19F3N6O3.C14H13N5O3.C13H11N5O3.C12H24B2O4.C12H17BN4O2.C9H10F3NO.C8H8BrNO3.C6H5BrN4/c1-12(15-5-3-4-6-17(15)34-22(23,24)25)27-19(32)16-9-14(11-30(2)20(16)33)13-7-8-31-18(10-13)28-21(26)29-31;1-18-7-9(5-10(12(18)20)13(21)22-2)8-3-4-19-11(6-8)16-14(15)17-19;1-17-6-8(4-9(11(17)19)12(20)21)7-2-3-18-10(5-7)15-13(14)16-18;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-11(2)12(3,4)19-13(18-11)8-5-6-17-9(7-8)15-10(14)16-17;1-6(13)7-4-2-3-5-8(7)14-9(10,11)12;1-10-4-5(9)3-6(7(10)11)8(12)13-2;7-4-1-2-11-5(3-4)9-6(8)10-11/h3-12H,1-2H3,(H2,26,29)(H,27,32);3-7H,1-2H3,(H2,15,17);2-6H,1H3,(H2,14,16)(H,20,21);1-8H3;5-7H,1-4H3,(H2,14,16);2-6H,13H2,1H3;3-4H,1-2H3;1-3H,(H2,8,10)
InChIKeyDMXNOFHVUBMZHS-UHFFFAOYSA-N
MW2235.31 g/mol
LogP11.38
Rot. Bonds14

About 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine

5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine (PubChem CID 164973938) has the molecular formula C96H107B3Br2F6N26O19 and a molecular weight of 2235.31 g/mol. Its IUPAC name is 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine.

Molecular Properties

Compound Name5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine
PubChem CID164973938
Molecular FormulaC96H107B3Br2F6N26O19
Molecular Weight2235.31 g/mol
Exact Mass2232.68
IUPAC Name5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine
SMILESCC(N)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(-c2ccn3nc(N)nc3c2)cn(C)c1=O)c1ccccc1OC(F)(F)F.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccn3nc(N)nc3c2)OC1(C)C.COC(=O)c1cc(-c2ccn3nc(N)nc3c2)cn(C)c1=O.COC(=O)c1cc(Br)cn(C)c1=O.Cn1cc(-c2ccn3nc(N)nc3c2)cc(C(=O)O)c1=O.Nc1nc2cc(Br)ccn2n1
InChIInChI=1S/C22H19F3N6O3.C14H13N5O3.C13H11N5O3.C12H24B2O4.C12H17BN4O2.C9H10F3NO.C8H8BrNO3.C6H5BrN4/c1-12(15-5-3-4-6-17(15)34-22(23,24)25)27-19(32)16-9-14(11-30(2)20(16)33)13-7-8-31-18(10-13)28-21(26)29-31;1-18-7-9(5-10(12(18)20)13(21)22-2)8-3-4-19-11(6-8)16-14(15)17-19;1-17-6-8(4-9(11(17)19)12(20)21)7-2-3-18-10(5-7)15-13(14)16-18;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-11(2)12(3,4)19-13(18-11)8-5-6-17-9(7-8)15-10(14)16-17;1-6(13)7-4-2-3-5-8(7)14-9(10,11)12;1-10-4-5(9)3-6(7(10)11)8(12)13-2;7-4-1-2-11-5(3-4)9-6(8)10-11/h3-12H,1-2H3,(H2,26,29)(H,27,32);3-7H,1-2H3,(H2,15,17);2-6H,1H3,(H2,14,16)(H,20,21);1-8H3;5-7H,1-4H3,(H2,14,16);2-6H,13H2,1H3;3-4H,1-2H3;1-3H,(H2,8,10)
InChIKeyDMXNOFHVUBMZHS-UHFFFAOYSA-N
XLogP11.38
TPSA587.91 Ų
H-Bond Donors8
H-Bond Acceptors43
Rotatable Bonds14
Heavy Atoms152
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002235.31
LogP ≤ 511.38
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(4S)-3,4-dihydro-2H-chromen-4-amine;N-[(4S)-3,4-dihydro-2H-chromen-4-yl]-2-methyl-8-propan-2-yl-3-[4-(trifluoromethyl)cyclohexen-1-yl]imidazo[1,2-b]pyridazine-7-carboxamide;ethyl 3-bromo-2-methyl-8-propan-2-ylimidazo[1,2-b]pyridazine-7-carboxylate;ethyl 2-methyl-8-propan-2-yl-3-[4-(trifluoromethyl)cyclohexen-1-yl]imidazo[1,2-b]pyridazine-7-carboxylate;2-methyl-8-propan-2-yl-3-[4-(trifluoromethyl)cyclohexen-1-yl]imidazo[1,2-b]pyridazine-7-carboxylic acid;4,4,5,5-tetramethyl-2-[4-(trifluoromethyl)cyclohexen-1-yl]-1,3,2-dioxaborolane
CID 163915425
5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-6-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-6-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-6-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-6-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;1-[2-(trifluoromethoxy)phenyl]ethanamine
CID 164952922

Frequently Asked Questions

What is the IUPAC name of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine?
The IUPAC name of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine (CID 164973938) is 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine.
What is the SMILES notation for 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine?
The canonical SMILES for 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine is CC(N)c1ccccc1OC(F)(F)F.CC(NC(=O)c1cc(-c2ccn3nc(N)nc3c2)cn(C)c1=O)c1ccccc1OC(F)(F)F.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccn3nc(N)nc3c2)OC1(C)C.COC(=O)c1cc(-c2ccn3nc(N)nc3c2)cn(C)c1=O.COC(=O)c1cc(Br)cn(C)c1=O.Cn1cc(-c2ccn3nc(N)nc3c2)cc(C(=O)O)c1=O.Nc1nc2cc(Br)ccn2n1.
What is the InChIKey of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine?
The InChIKey is DMXNOFHVUBMZHS-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H19F3N6O3.C14H13N5O3.C13H11N5O3.C12H24B2O4.C12H17BN4O2.C9H10F3NO.C8H8BrNO3.C6H5BrN4/c1-12(15-5-3-4-6-17(15)34-22(23,24)25)27-19(32)16-9-14(11-30(2)20(16)33)13-7-8-31-18(10-13)28-21(26)29-31;1-18-7-9(5-10(12(18)20)13(21)22-2)8-3-4-19-11(6-8)16-14(15)17-19;1-17-6-8(4-9(11(17)19)12(20)21)7-2-3-18-10(5-7)15-13(14)16-18;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-11(2)12(3,4)19-13(18-11)8-5-6-17-9(7-8)15-10(14)16-17;1-6(13)7-4-2-3-5-8(7)14-9(10,11)12;1-10-4-5(9)3-6(7(10)11)8(12)13-2;7-4-1-2-11-5(3-4)9-6(8)10-11/h3-12H,1-2H3,(H2,26,29)(H,27,32);3-7H,1-2H3,(H2,15,17);2-6H,1H3,(H2,14,16)(H,20,21);1-8H3;5-7H,1-4H3,(H2,14,16);2-6H,13H2,1H3;3-4H,1-2H3;1-3H,(H2,8,10).
What are the key properties of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine?
5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine has a molecular weight of 2235.31 g/mol, XLogP of 11.38, 14 rotatable bonds, 8 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylic acid;5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxo-N-[1-[2-(trifluoromethoxy)phenyl]ethyl]pyridine-3-carboxamide;7-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine;methyl 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1-methyl-2-oxopyridine-3-carboxylate;methyl 5-bromo-1-methyl-2-oxopyridine-3-carboxylate;7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1-[2-(trifluoromethoxy)phenyl]ethanamine is sourced from PubChem (CID 164973938), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).